Sponsor the team of researchers working to combat sarcomas

Sponsor the team of researchers fighting sarcomas

Month after month, your sponsorship accelerates sarcoma research toward new breakthroughs

Sarcomas are aggressive cancers that affect the body’s soft tissues, internal organs, or bones (osteosarcomas). Because they are rare, sarcomas have benefited very little from therapeutic advances over the past 30 years.

Our personalized medicine research program dedicated to sarcomas offers hope to patients. By deploying state-of-the-art molecular analysis methods, it aims to determine the most effective treatment for each patient as soon as they are diagnosed.

Supporting the research team dedicated to sarcomas is essential to achieving tangible advances for patients.

Through your sponsorship, become a driving force for innovation and accelerate sarcoma research for the direct benefit of patients!

By developing new personalized therapeutic strategies, we are advancing sarcoma research through four key areas of focus:

● Identifying and developing new targeted
therapies ● Gaining a better understanding of tumor
biology ● Developing new preclinical
research models ● Launching a one-day diagnostic consultation

Goal: Innovate to improve sarcoma care

Benefits for patients:

● Launching a clinical
trial ● Access to the most innovative
treatments ● Improving patient survival

Annual program budget: €150,000

 

Becoming a sponsor means taking part in a major scientific adventure every day

What if, for just €8.50 a month*, you could help accelerate sarcoma research?

With a regular donation of at least €25 per month (or €8.50 after tax deduction), you become a valued partner of your research team.

Your sponsorship provides essential support for bringing innovative sarcoma projects to fruition.

Our research on sarcomas
will advance thanks to you

Dr. Sophie Postel-Vinay, physician-researcher and head of the sarcoma research laboratory

Your support is essential to our research. Because sarcoma is a rare disease, the pharmaceutical industry has little interest in it: only academic research will enable therapeutic progress. Donations are therefore essential to enable us to carry out our exploratory work and validate our research hypotheses, which can then be supported by institutions and public grants. By supporting our team, you will be a key player and the driving force behind future innovations in the understanding and treatment of sarcomas. Thank you.

Dr. Charles Honoré, Chair of the Sarcoma Committee and Chief of the Department of Visceral Oncological Surgery at Gustave Roussy

Sponsoring our research team dedicated to sarcomas is a unique opportunity for us to better understand this disease and innovate in its treatment. Supporting this research on a rare cancer also means keeping alive the spirit of Gustave Roussy: treating all cancers and offering all patients the best chance of a cure.

 

* after a 66% tax deduction

 

 Colorectal Cancer Childhood Cancer Gynecologic Cancers Living Better with Cancer Skin Cancer Lung Cancer Prostate Cancer Sarcomas Breast Cancer Brain Tumors